The present invention relates to pyridyl or pyrazinyl compounds carrying a methyl- bound N-amide moiety derived from an α-amino acid of formula I where the variables are as defined in the claims and the description. The invention further relates to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT2C receptor, and to their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of the 5-HT2C receptor.
本发明涉及携带自公式I中
α-氨基酸衍生的甲基结合N-酰胺基团的
吡啶基或
吡嗪基化合物,其中变量如权利要求和说明中所定义。该发明还涉及含有这些化合物的药物组合物,以及它们作为5-HT2C受体的调节剂,特别是激动剂或部分激动剂的用途,以及它们用于制备用于预防或治疗对5-HT2C受体调节产生反应的疾病和紊乱的用途。